Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 5Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 4Gastrointestinal 1

Conditions

Stomatitis 4Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Pancreatic Neoplasms 1Oral Ulcer 1Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × avasopasem manganese × Clear all
NCT03340974 2023-12-15

Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer

Galera Therapeutics, Inc.

Phase 1/2 Completed
42 enrolled 13 charts
Gastrointestinal

Pancreatic Neoplasms

NCT03689712 2023-10-24

ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

Galera Therapeutics, Inc.

Phase 3 Completed
455 enrolled 11 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Stomatitis, Oral Ulcer

NCT04529850 2022-08-16

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
38 enrolled 10 charts
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT02508389 2021-09-20

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Galera Therapeutics, Inc.

Phase 2 Completed
223 enrolled 17 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Stomatitis

NCT01921426 2016-09-22

A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck

Galera Therapeutics, Inc.

Phase 1 Completed
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡